Loading organizations...
Loading organizations...
BIOS: Neural engineering company developing an AI platform to decode neural signals for precision neural digital therapies and chronic disease treatment.
Based in Cambridge, United Kingdom, BIOS develops an artificial intelligence-driven neural engineering platform that decodes the human nervous system to create precision bioelectronic treatments for chronic diseases. The company's software translates real-time nerve impulses into actionable clinical data, allowing medical device manufacturers and pharmaceutical companies to integrate neural mapping directly into existing surgical implants and drug discovery processes. Currently operating with an estimated 30 to 50 employees, the enterprise has secured over $20 million in total venture funding, including a $14 million Series A round and a portion of a $9.7 million grant from the National Institutes of Health. BIOS is financially backed by several prominent institutional investors, including Y Combinator, MassMutual Ventures, Selvedge Venture, and XTX Ventures. The biotechnology company was originally founded in 2015 by computational neuroscientist Emil Hewage and bioengineer Oliver Armitage.
BIOS has raised $25.0M across 2 funding rounds.
BIOS has raised $25.0M in total across 2 funding rounds.
BIOS Technologies is a U.S.-based IT services and consulting firm specializing in managed IT solutions, cybersecurity, and holistic tech strategies for small and medium-sized businesses (SMBs), primarily in the Gulf Coast region including the New Orleans metro area.[1][2][3][5][6] The company resolves workplace disruptions through proactive monitoring, routine maintenance, innovative IT services like virtualization, server management, and modern workplace setups, serving clients in sectors such as healthcare and law firms to minimize downtime and enhance efficiency.[1][2][5][6] With 11-50 employees and a focus on rapid response (under 15 minutes via human agents), BIOS drives client growth by addressing complex IT challenges, fostering high renewal rates after the first year.[1][5][6]
BIOS Technologies operates from headquarters in Metairie and New Orleans, Louisiana, as a privately-held firm in the technology services industry, though specific founding year and key partners are not detailed in available records.[4][5] It emerged to target SMBs facing business and security risks from unmanaged technology, evolving into a dedicated provider of superior IT support in the New Orleans metro area with partnerships including VMware, SonicWall, Microsoft, Meraca, and Dell.[5] Early traction is evident in client testimonials from law firms and healthcare organizations like Sapphire Health, highlighting initial system setups, multi-office efficiency, and ongoing protection that smoothed operations and ensured compliance.[5]
BIOS Technologies rides the wave of escalating cybersecurity threats and IT complexity for SMBs, where unmanaged tech poses profitability risks amid rising AI-driven attacks, cloud adoption, and remote work demands.[6] Timing aligns with 2025 trends like AI in cybersecurity for anomaly detection/phishing prevention, co-managed IT, and robust strategies for audits/remote optimization, positioning the firm to help businesses stay ahead of sophisticated threats without in-house expertise.[2][6] Market forces favoring BIOS include SMBs' need for affordable, localized support in the Gulf Coast, influencing the ecosystem by enabling regional firms—e.g., law practices and healthcare providers—to compete through reliable tech, reducing downtime, and fostering growth in a post-pandemic hybrid world.[5][6]
BIOS Technologies is poised to expand its Gulf Coast dominance by leaning into 2025 IT trends like AI-enhanced defenses, cloud integration, and co-managed models, potentially scaling beyond SMBs via strategic partnerships.[6] Evolving threats will amplify demand for its proactive, human-led services, while blog insights on AI risks and IT audits signal thought leadership that could attract larger clients or acquisitions. As regional IT reliability underpins broader economic resilience, BIOS's influence may grow, empowering more SMBs to thrive in an AI-accelerated landscape—resolving disruptions today to fuel tomorrow's successes.[6]
BIOS has raised $25.0M in total across 2 funding rounds.
BIOS's investors include 7GC & Co, Ada Ventures, Builders, Friedom Partners, FTX Ventures, GoAhead Ventures, Human Augmentation Syndicate, Innovation Endeavors, Lakeside Capital, Scalebridge Capital, Spark Capital, SparkLabs Group.
BIOS has raised $25.0M across 2 funding rounds. Most recently, it raised $20.0M Series A in June 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 1, 2023 | $20.0M Series A | 7GC & Co, Ada Ventures, Builders, Friedom Partners, FTX Ventures, GoAhead Ventures, Human Augmentation Syndicate, Innovation Endeavors, Lakeside Capital, Scalebridge Capital, Spark Capital, SparkLabs Group, Adeel Hussain, Alan MacIntosh, Charlie Songhurst, Dustin Moskovitz, Elia Montanari, Evan Cheng, Ishani Patel, Jaan Tallinn, Jason Haider, Preetha Parthasarathy, Siddharth Singhal, Vikas Sabnani | |
| Dec 1, 2018 | $5.0M Seed | Ariel Poler, AME Cloud Ventures, Alan MacIntosh | Alumni Ventures, DCM, Drive Capital, Footwork, Human Augmentation Syndicate, Sinai Ventures, Team Ignite Ventures, Trinity Ventures, Vine Ventures LP, Martin Schrimpff, Charlie Songhurst, Endure Capital, Heuristic Capital, K5 Ventures |